| A pharmacogenetic versus a clinical algorithm for warfarin dosing SE Kimmel, B French, SE Kasner, JA Johnson, JL Anderson, BF Gage, ... New England Journal of Medicine 369 (24), 2283-2293, 2013 | 850 | 2013 |
| Minocycline for short‐term neuroprotection HF Elewa, H Hilali, DC Hess, LS Machado, SC Fagan Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 26 (4 …, 2006 | 214 | 2006 |
| Increased hemorrhagic transformation and altered infarct size and localization after experimental stroke in a rat model type 2 diabetes A Ergul, MM Elgebaly, ML Middlemore, W Li, H Elewa, JA Switzer, C Hall, ... BMC neurology 7, 1-7, 2007 | 149 | 2007 |
| Diverse effects of statins on angiogenesis: new therapeutic avenues HF Elewa, AB El‐Remessy, PR Somanath, SC Fagan Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 30 (2 …, 2010 | 86 | 2010 |
| Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke A Kozak, A Ergul, AB El-Remessy, MH Johnson, LS Machado, HF Elewa, ... Stroke 40 (5), 1870-1876, 2009 | 77 | 2009 |
| Blood pressure lowering after experimental cerebral ischemia provides neurovascular protection HF Elewa, A Kozak, MH Johnson, A Ergul, SC Fagan Journal of hypertension 25 (4), 855-859, 2007 | 70 | 2007 |
| Vascular protection with candesartan after experimental acute stroke in hypertensive rats: a dose-response study W Kozak, A Kozak, MH Johnson, HF Elewa, SC Fagan Journal of Pharmacology and Experimental Therapeutics 326 (3), 773-782, 2008 | 68 | 2008 |
| Therapeutic drug monitoring of voriconazole in the management of invasive fungal infections: a critical review H Elewa, E El-Mekaty, A El-Bardissy, MHH Ensom, KJ Wilby Clinical pharmacokinetics 54, 1223-1235, 2015 | 59 | 2015 |
| A survey on the awareness and attitude of pharmacists and doctors towards the application of pharmacogenomics and its challenges in Q Atar H Elewa, D Alkhiyami, D Alsahan, A Abdel‐Aziz Journal of Evaluation in Clinical Practice 21 (4), 703-709, 2015 | 58 | 2015 |
| Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic review and a … MN Elshafei, MFH Mohamed, A El-Bardissy, MB Ahmed, I Abdallah, ... Journal of Thrombosis and Thrombolysis 51, 388-396, 2021 | 57 | 2021 |
| Early atorvastatin reduces hemorrhage after acute cerebral ischemia in diabetic rats HF Elewa, A Kozak, AB El-Remessy, RF Frye, MH Johnson, A Ergul, ... Journal of Pharmacology and Experimental Therapeutics 330 (2), 532-540, 2009 | 55 | 2009 |
| Genetic variation in the β2 subunit of the voltage-gated calcium channel and pharmacogenetic association with adverse cardiovascular outcomes in the international verapamil SR … Y Niu, Y Gong, TY Langaee, HM Davis, H Elewa, AL Beitelshees, JI Moss, ... Circulation: Cardiovascular Genetics 3 (6), 548-555, 2010 | 52 | 2010 |
| Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis Front Cardiovasc Med . 7, doi: 10.3389/fcvm.2020.598846. eCollect, 2021 | 44* | 2021 |
| A review of pharmacogenetics of antimalarials and associated clinical implications H Elewa, KJ Wilby European journal of drug metabolism and pharmacokinetics 42, 745-756, 2017 | 39 | 2017 |
| Evaluation of pharmacist‐based compared to doctor‐based anticoagulation management in Q atar H Elewa, F Jalali, N Khudair, N Hassaballah, O Abdelsamad, ... Journal of evaluation in clinical practice 22 (3), 433-438, 2016 | 37 | 2016 |
| Potential therapeutic effects of sodium glucose-linked cotransporter 2 inhibitors in stroke FA Al Hamed, H Elewa Clinical Therapeutics 42 (11), e242-e249, 2020 | 35 | 2020 |
| Pharmacogenomics In Pharmacy Practice: Current Perspectives A Elewa, Hazem, Awaisu Integrated Pharmacy and Research Practice 8 (2230-5254), 97-104, 2019 | 34 | 2019 |
| Patients satisfaction with warfarin and willingness to switch to dabigatran: a patient survey HF Elewa, CE DeRemer, K Keller, J Gujral, TV Joshua Journal of thrombosis and thrombolysis 38, 115-120, 2014 | 34 | 2014 |
| Clinical and pharmacokinetic outcomes of peak–trough-based versus trough-based vancomycin therapeutic drug monitoring approaches: A pragmatic randomized controlled trial FK Al-Sulaiti, AM Nader, MO Saad, A Shaukat, R Parakadavathu, ... European Journal of Drug Metabolism and Pharmacokinetics 44, 639-652, 2019 | 33 | 2019 |
| The impact of genetic and non-genetic factors on warfarin dose prediction in MENA region: a systematic review LA Bader, H Elewa PloS one 11 (12), e0168732, 2016 | 32 | 2016 |
Ahmed AwaisuDepartment of Clinical Pharmacy, College of Pharmacy, QU Health, Qatar UniversityVerified email at qu.edu.qa
